Related Experiment Video
Updated: May 10, 2025

Studying Effects of Cigarette Smoke on Pseudomonas Infection in Lung Epithelial Cells
Published on: May 11, 2020
From coughs to complications: the story of Chlamydia pneumoniae
Florian Tagini1,2, Mirja Puolakkainen3, Gilbert Greub1,2
1Department of Laboratory Medicine and Pathology, Institute of Microbiology, Lausanne University Hospital, Lausanne, Switzerland.
Abstract:
Chlamydia pneumoniae is an obligate intracellular bacterium and a significant cause of respiratory infections. It is associated with upper and lower respiratory tract diseases, including bronchitis and pneumonia. The pathogen employs specific virulence factors, such as the Type III Secretion System (T3SS) and Inc proteins, to invade and subvert host cell machinery during its peculiar developmental life cycle. Chronic infections have been linked to asthma and, more controversially, to atherosclerosis and neurodegenerative diseases. Diagnosis primarily relies on PCR-based molecular assays, while treatment includes macrolides, tetracyclines or fluoroquinolones. Despite its clinical relevance, research on C. pneumoniae has declined in recent years, highlighting the need for renewed scientific focus.
Insights
Chlamydia pneumoniae causes respiratory infections and uses virulence factors like T3SS to infect cells. Renewed research focus is needed for this clinically relevant bacterium.
Area of Science:
- Microbiology
- Infectious Diseases
- Bacteriology
Background:
- Chlamydia pneumoniae is an obligate intracellular bacterium responsible for significant respiratory tract infections.
- Associated diseases range from bronchitis and pneumonia to chronic conditions like asthma, atherosclerosis, and neurodegenerative disorders.
Purpose of the Study:
- To review the virulence factors, life cycle, diagnosis, and treatment of Chlamydia pneumoniae.
- To emphasize the need for increased research focus on this clinically relevant pathogen.
Main Methods:
- Literature review of Chlamydia pneumoniae research.
- Analysis of virulence factors including the Type III Secretion System (T3SS) and Inc proteins.
- Overview of diagnostic methods (PCR) and treatments (macrolides, tetracyclines, fluoroquinolones).
Main Results:
- Chlamydia pneumoniae utilizes T3SS and Inc proteins for host cell invasion and subversion.
- Chronic infections are linked to asthma and potentially atherosclerosis and neurodegenerative diseases.
- PCR assays are standard for diagnosis, with antibiotic treatment options available.
Conclusions:
- Despite its clinical significance, research on Chlamydia pneumoniae has recently declined.
- A renewed scientific focus is crucial to better understand and combat Chlamydia pneumoniae infections and their sequelae.
More Related Videos
04:03Author Spotlight: Evaluating the Therapeutic Efficacy of Moving Cupping Along Meridians for Acute Exacerbation of COPD
Published on: September 27, 2024
12:21A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness
Published on: September 28, 2022
Related Concept Videos
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Asthma-III: Symptoms and Complications
Classification of Asthma
Pulmonary Cycle: Exhalation
Pneumonia III: Complications and Assessment
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...